Search Results - "DUNN, Rodney"

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form by Skolarus, Ted A, Dunn, Rodney L, Sanda, Martin G, Chang, Peter, Greenfield, Thomas K, Litwin, Mark S, Wei, John T

“…Objective To establish a score threshold that constitutes a clinically relevant change for each domain of the Expanded Prostate Cancer Index Composite (EPIC)…”
Get full text

Editorial Comment on “Effect of a Modified Technique of Posterior Reconstruction by Iliopectineal Ligament Suspension During Robot-assisted Laparoscopic Radical Prostatectomy on Early Continence: A Randomized Controlled Trial” by Lane, Brian R., Dunn, Rodney L., Ginsburg, Kevin B., Borza, Tudor

Get full text

Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors by Szymanski, Konrad M, Wei, John T, Dunn, Rodney L, Sanda, Martin G

“…Objectives Widespread implementation of health-related quality-of-life (HRQOL) measurement in prostate cancer practice and research requires concise…”
Get full text

Interstate Telehealth Use By Medicare Beneficiaries Before And After COVID-19 Licensure Waivers, 2017–20 by Andino, Juan J, Zhu, Ziwei, Surapaneni, Mihir, Dunn, Rodney L, Ellimoottil, Chad

“…During the COVID-19 pandemic, all fifty states and Washington, D.C., passed licensure waivers that allowed patients to participate in telehealth visits with…”
Get full text

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment by Tomlins, Scott A, Day, John R, Lonigro, Robert J, Hovelson, Daniel H, Siddiqui, Javed, Kunju, L. Priya, Dunn, Rodney L, Meyer, Sarah, Hodge, Petrea, Groskopf, Jack, Wei, John T, Chinnaiyan, Arul M

“…Abstract Background TMPRSS2:ERG (T2:ERG) and prostate cancer antigen 3 (PCA3) are the most advanced urine-based prostate cancer (PCa) early detection…”
Get full text

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors by Sanda, Martin G, Dunn, Rodney L, Michalski, Jeff, Sandler, Howard M, Northouse, Laurel, Hembroff, Larry, Lin, Xihong, Greenfield, Thomas K, Litwin, Mark S, Saigal, Christopher S, Mahadevan, Arul, Klein, Eric, Kibel, Adam, Pisters, Louis L, Kuban, Deborah, Kaplan, Irving, Wood, David, Ciezki, Jay, Shah, Nikhil, Wei, John T

“…Quality of life and satisfaction with outcome of treatment were ascertained by questionnaires in men with prostate cancer and their spouses or partners after…”
Get full text

Prediction of Erectile Function Following Treatment for Prostate Cancer by Alemozaffar, Mehrdad, Regan, Meredith M, Cooperberg, Matthew R, Wei, John T, Michalski, Jeff M, Sandler, Howard M, Hembroff, Larry, Sadetsky, Natalia, Saigal, Christopher S, Litwin, Mark S, Klein, Eric, Kibel, Adam S, Hamstra, Daniel A, Pisters, Louis L, Kuban, Deborah A, Kaplan, Irving D, Wood, David P, Ciezki, Jay, Dunn, Rodney L, Carroll, Peter R, Sanda, Martin G

“…CONTEXT Sexual function is the health-related quality of life (HRQOL) domain most commonly impaired after prostate cancer treatment; however, validated tools…”
Get full text

Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer by Jacobs, Bruce L, Zhang, Yun, Schroeck, Florian R, Skolarus, Ted A, Wei, John T, Montie, James E, Gilbert, Scott M, Strope, Seth A, Dunn, Rodney L, Miller, David C, Hollenbeck, Brent K

“…IMPORTANCE The use of advanced treatment technologies (ie, intensity-modulated radiotherapy [IMRT] and robotic prostatectomy) for prostate cancer is…”
Get full text

Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality by Vickers, Andrew J., Assel, Melissa, Dunn, Rodney L., Zabor, Emily C., Kattan, Michael W., van Smeden, Maarten, Dahly, Darren

“…Observational studies often dance around the issue of causality. We propose guidelines to ensure that papers refer to whether or not the study aim is to…”
Get full text

Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years: Results From a Statewide Surgical Improvement Collaborative by Agochukwu-Mmonu, Nnenaya, Qi, Ji, Dunn, Rodney L, Montie, James, Wittmann, Daniela, Miller, David, Martin, Rabia, Kim, Tae, Johnston, 3rd, William K, Peabody, James

“…Of patient-reported outcomes for individuals undergoing radical prostatectomy, sexual function outcomes are among the most reported and the most detrimental to…”
Get more information

Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality by Vickers, Andrew J, Assel, Melissa, Dunn, Rodney L, Zabor, Emily C, Kattan, Michael W, van Smeden, Maarten, Dahly, Darren

Get full text

Guidelines for Reporting Observational Research in Urology: The Importance of Clear Reference to Causality by Vickers, Andrew J., Assel, Melissa, Dunn, Rodney L., Zabor, Emily C., Kattan, Mike W., van Smeden, Maarten, Dahly, Darren

Get full text

Accountable care organizations and use of surgery among patients with Alzheimer disease and related dementias by Maganty, Avinash, Dunn, Rodney L, Bynum, Julie P W, Hollenbeck, Brent K

“…To understand the effects of accountable care organizations (ACOs) on use of surgery in patients with Alzheimer disease and related dementias (ADRD)…”
Get full text

Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set by Vickers, Andrew J., Tin, Amy L., Singh, Karandeep, Dunn, Rodney L., Mulhall, John

“…The International Index of Erectile Function (IIEF) is the predominant patient-reported outcomes instrument for assessing male sexual function. There are…”
Get full text

Guidelines for reporting observational research in urology: the importance of clear reference to causality by Vickers, Andrew J., Assel, Melissa, Dunn, Rodney L., Zabor, Emily C., Kattan, Michael W., Smeden, Maarten, Dahly, Darren

Get full text

Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer by Abusamra, Sophia M, Solorzano, Marissa A, Luke, Mallory, Quarles, Jake, Jacobs, Michelle F, Das, Sanjay, Kasputis, Amy, Okoth, Linda A, Patel, Milan, Seymore, Mariana, Caram, Megan E V, Dunn, Rodney L, Merajver, Sofia D, Stoffel, Elena M, Reichert, Zachery R, Morgan, Todd M

“…Indications for germline testing in prostate cancer patients have expanded substantially over the past decade. With a near-universal shortage of genetic…”
Get full text

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort by Wessells, Hunter, Braffett, Barbara H, Holt, Sarah K, Jacobson, Alan M, Kusek, John W, Cowie, Catherine, Dunn, Rodney L, Sarma, Aruna V

“…Type 1 diabetes has been associated with high rates of urinary and sexual problems, but the cumulative burden and overlap of these complications are unknown…”
Get full text

Ambulatory Surgery Centers and Outpatient Procedure Use Among Medicare Beneficiaries by Hollenbeck, Brent K., Dunn, Rodney L., Suskind, Anne M., Zhang, Yun, Hollingsworth, John M., Birkmeyer, John D.

“…Background: There has been a strong push to move outpatient surgery from hospital settings to ambulatory surgery centers (ASCs). Despite the efficiency…”
Get full text

Development and Validation of Crosswalks for Patient-reported Sexual and Urinary Outcomes Between Commonly Used Instruments by Singh, Karandeep, Tin, Amy L., Dunn, Rodney L., Kim, Tae, Vickers, Andrew J.

“…Patient-reported outcome measures (PROMs) have become widely adopted in the care of patients with prostate cancer, but there is no validated crosswalk between…”
Get full text

Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial by HUSSAIN, Maha H. A, MACVICAR, Gary R, CHEN, Helen, SMITH, David C, PETRYLAK, Daniel P, DUNN, Rodney L, VAISHAMPAYAN, Ulka, LARA, Primo N, CHATTA, Gurkamal S, NANUS, David M, GLODE, L. Michael, TRUMP, Donald L

“…We investigated the safety and efficacy (response rates, time to disease progression, survival) of trastuzumab, carboplatin, gemcitabine, and paclitaxel in…”
Get full text